Global Ophthalmic Drugs Market Size & Share Will Reach USD 37,700 Million By 2026

Ophthalmic Drug Market

Ophthalmic Drug Market

Global ophthalmic drugs market reach around USD 37,700 million by 2026, at a CAGR of 4.6% from 2020 to 2026.

NEW YORK, UNITED STATES, August 24, 2020 / — Facts and Factors has authored “Ophthalmic Drug Market By Type (Over-the-Counter Drugs and Prescription Drugs), By Drug Class (Anti-inflammatory Drugs, Anti-Infective Drugs, Anti-Allergic Drugs, Anti-Glaucoma Drugs, and Others), By Disease Indication (Inflammation/ Infection, Retinal Disorders, Dry Eye, Glaucoma, Allergies, and Others), By Distribution Channel (Online Sales, Retail Pharmacies, Hospital Pharmacies, and Others), and By Region: Global Industry Perspective, Market Size, Statistical Research, Market Intelligence, Comprehensive Analysis, Historical Trends, and Forecasts, 2019–2026”. Based on our analysis, the global ophthalmic drugs market in 2019 is over USD 27,000 million and is expected to reach around USD 37,700 million by 2026. The anticipated CAGR for the global ophthalmic drugs market is around 4.6% from 2020 to 2026.

Ophthalmic drugs, also referred to as eye medications, are solid, liquid, or semi-solid formulations that are intended to apply on the eyelids and conjunctiva. The drugs are certain emulsions, ointments, and/or active pharmaceutical ingredient(s).

Request an Exclusive Free Sample Report of Ophthalmic Drug Market:

High prevalence of ocular disease cases likely to bolster the ophthalmic drug market

The visual impairment incidences have been surging considerably worldwide irrespective of the age group. This challenging situation has urged drug manufacturers and pharmaceutical companies to design and supply effective medications against this rapidly spreading disorder. Hence, the introduction of novel effective ophthalmic drugs bolsters the global ophthalmic drug market. Exposure to air and water pollution poses a greater risk to the eyes. Thus, surging the demand for the drugs and propelling the global ophthalmic drug market.

Ophthalmic drugs-associated side effects expected to hamper the ophthalmic market

Eye treatment involves a risky operation and has various side effects. In some cases, ophthalmic drugs fail to maintain the intraocular pressure of the eye while treatment. In most of the cases, the medicine may cause internal burning in the eye and/or temporary blurred vision. Owing to these attributes, the ophthalmic drugs market enters the declining phase.

Enquire more about this report before purchase @

(You may enquire a report quote OR available discount offers to our sales team before purchase.)

Anti-infective drug class leads the global ophthalmic drug market

The anti-infective drug category, from the past few years, has been holding the dominating position in the global ophthalmic market. In 2019, the category accounts for more than one-third of the market share in terms of revenue. However, the anti-glaucoma drugs are projected to augment at a relatively faster CAGR throughout the forecast period.

Over-the-counter drug type accounts for higher sales and revenue share

Based on the type segment, ophthalmic drugs are categorized into prescription drugs and over-the-counter drugs. Among both, over-the-counter drug type holds around two-third share in the overall sales and revenue. However, the prescription drug category is anticipated to grow at higher CAGR between 2020 and 2026.

Request Customized Copy of Report @

(We customize your report according to your research need. Ask our sales team for report customization.

Retail pharmacies expect better sales and revenue share during the forecast period

Despite the consecutive decline in the volume sales, the revenue generated by retail pharmacies is thrusting at a considerable rate. Based on the forecast, the drug category is likely to follow the same revenue growth trend. However, the hospital pharmacies category holds the leading position in the global market revenue generation.

Key market players

Some of the key players driving the global ophthalmic drugs market are Santen Pharmaceutical Co. Ltd., Bayer AG, ALLERGAN, Novartis AG, Pfizer Inc., Genentech Inc., Oxurion NV, Bausch Health Companies Inc., and Regeneron Pharmaceuticals Inc., among others.

In February 2019, Bausch Health Companies Inc.procures the patent medicine EM-100 investigational eye drop designed by Eton Pharmaceuticals EM-100 for the treatment of itching associated with the allergies in eyes.

For More Report Details:

The global ophthalmic drugs market is segmented as:

Global Ophthalmic Drugs Market: Type Segmentation Analysis

Over-the-Counter Drugs
Prescription Drugs
Global Ophthalmic Drugs Market: Drug Class Segmentation Analysis

Anti-Infective Drugs

Anti-Bacterial Drugs
Anti-Fungal Drugs
Anti-Viral Drugs
Anti-Glaucoma Drugs
Prostaglandin Analogs
Alpha Agonist
Combined Medication

Anti-inflammatory Drugs

Non-Steroidal Anti-Inflammatory Drugs

Anti-Allergic Drugs

Global Ophthalmic Drugs Market: Disease Indication Segmentation Analysis

Inflammation/ Infection
Retinal Disorders
Dry Eye

Global Ophthalmic Drugs Market: Distribution Channel Segmentation Analysis

Online Sales
Retail Pharmacies
Hospital Pharmacies

About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Sanu Thomas
Facts & Factors
+1 855-465-4651
email us here
Visit us on social media:

About Danh Sách Top - Hot Nhất Năm